Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...

What you need to know The prevalence of heart failure across Europe is estimated to be 1-2% of adults.1 In the UK, this places a substantial burden on patients and healthcare resources, including ...

Characterized by weakened or damaged heart musculature, heart failure results in the gradual buildup of fluid in a patient's lungs, legs, feet, and other parts of the body. The condition is chronic ...

For years, researchers have suspected that a hormone called relaxin could be an effective treatment for certain ...

Scarring of heart tissue can be slowed but not stopped, and can lead to heart failure. But a new study has shown that an existing immunotherapy could stop scar tissue formation after heart attacks.

In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...

Chronic, mild dehydration quietly increases the workload on your cardiovascular system. Even mild dehydration reduces blood ...

Researchers have reduced scar formation and improved heart function in mouse models of heart failure using a monoclonal antibody treatment, similar to that approved by the FDA to treat other ...

Up to a million people in the UK are already diagnosed with heart disease with a futher 200,000 being added every year ...

Segment showcases SynCardia Total Artificial Heart supporting patients with advanced heart failure and next-generation development programs ...